Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06428487
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2024-03-05
Brief Title:
Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer
Sponsor:
Blokhins Russian Cancer Research Center
Organization:
Blokhins Russian Cancer Research Center
Organization Data
Organization:
Blokhins Russian Cancer Research Center
Class:
OTHER
Study ID:
125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blokhins Russian Cancer Research Center
Lead Sponsor Class:
OTHER
Responsible Party:
Mikhail Fedyanin
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Blokhins Russian Cancer Research Center
Old Name:
None
Old Organization:
None